CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism

被引:188
作者
Dai, ZH
Li, Q
Wang, YN
Gao, G
Diggs, LS
Tellides, G
Lakkis, FG
机构
[1] Yale Univ, Sch Med, Nephrol Sect, Dept Internal Med, New Haven, CT USA
[2] Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06510 USA
[3] Yale Univ, Sch Med, Dept Surg, Sect Cardiothorac Surg, New Haven, CT 06510 USA
[4] Yale Univ, Sch Med, Dept Internal Med, Cardiol Sect, New Haven, CT 06510 USA
关键词
D O I
10.1172/JCI200419727
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
CD4(+)CD25(+) regulatory T (Treg) cells suppress naive T cell responses, prevent autoimmunity, and delay allograft rejection. It is not known, however, whether Treg cells suppress allograft rejection mediated by memory T cells, as the latter mount faster and stronger immune responses than their naive counterparts. Here we show that antigen-induced, but not naive, Treg cells suppress allograft rejection mediated by memory CD8(+) T cells. Suppression was allospecific, as Treg cells induced by third-party antigens did not delay allograft rejection. In vivo and in vitro analyses revealed that the apoptosis of allospecific memory CD8(+) T cells is significantly increased in the presence of antigen-induced Treg cells, while their proliferation remains unaffected. Importantly, neither suppression of allograft rejection nor enhanced apoptosis of memory CD8(+) T cells was observed when Treg cells lacked CD30 or when CD30 ligand-CD30 interaction was blocked with anti-CD30 ligand Ab. This study therefore provides direct evidence that pathogenic memory T cells are amenable to suppression in an antigen-specific manner and identifies CD30 as a molecule that is critical for the regulation of memory T cell responses.
引用
收藏
页码:310 / 317
页数:8
相关论文
共 44 条
  • [1] Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
  • [2] Impaired negative selection of T cells in Hodgkin's disease antigen CD30-deficient mice
    Amakawa, R
    Hakem, A
    Kundig, TM
    Matsuyama, T
    Simard, JJL
    Timms, E
    Wakeham, A
    Mittruecker, HW
    Griesser, H
    Takimoto, H
    Schmits, R
    Shahinian, A
    Ohashi, PS
    Penninger, JM
    Mak, TW
    [J]. CELL, 1996, 84 (04) : 551 - 562
  • [3] The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice
    Ansari, MJI
    Salama, AD
    Chitnis, T
    Smith, RN
    Yagita, H
    Akiba, H
    Yamazaki, T
    Azuma, M
    Iwai, H
    Khoury, SJ
    Auchincloss, H
    Sayegh, MH
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (01) : 63 - 69
  • [4] Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
    Asano, M
    Toda, M
    Sakaguchi, N
    Sakaguchi, S
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) : 387 - 396
  • [5] An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
    Asseman, C
    Mauze, S
    Leach, MW
    Coffman, RL
    Powrie, F
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (07) : 995 - 1003
  • [6] Bowen MA, 1996, J IMMUNOL, V156, P442
  • [7] Recall and propagation of allospecific memory T cells independent of secondary lymphoid organs
    Chalasani, G
    Dai, ZH
    Konieczny, BT
    Baddoura, FK
    Lakkis, FG
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (09) : 6175 - 6180
  • [8] Cutting edge: Secondary lymphoid organs are essential for maintaining the CD4, but not CD8, naive T cell pool
    Dai, ZH
    Lakkis, FG
    [J]. JOURNAL OF IMMUNOLOGY, 2001, 167 (12) : 6711 - 6715
  • [9] Dai ZH, 1998, J IMMUNOL, V161, P1659
  • [10] Davies DK, 1999, INST PHYS CONF SER, V163, P3